The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACHILLION PHARMACEUTICALS IN | COM | 00448Q201 | 6,474 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| SYNERGY PHARMACEUTICALS DEL | COM NEW | 871639308 | 3,402 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| ALCOBRA LTD | SHS | M2239P109 | 3,140 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| SPECTRANETICS CORP | COM | 84760C107 | 6,551 | 435,000 | SH | SOLE | 435,000 | 0 | 0 | ||
| GENMARK DIAGNOSTICS INC | COM | 372309104 | 3,182 | 410,000 | SH | SOLE | 410,000 | 0 | 0 | ||
| NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 5,884 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| CATALYST PHARMACEUTICALS INC | COM | 14888U101 | 921 | 376,000 | SH | SOLE | 376,000 | 0 | 0 | ||
| TANDEM DIABETES CARE INC | COM | 875372104 | 4,134 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| TONIX PHARMACEUTICALS HLDG C | COM NEW | 890260201 | 2,685 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| VERACYTE INC | COM | 92337F107 | 2,520 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| VITAE PHARMACEUTICALS INC | COM | 92847N103 | 4,978 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
| ZELTIQ AESTHETICS INC | COM | 98933Q108 | 7,846 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 8,913 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| NUVASIVE INC | COM | 670704105 | 12,445 | 230,000 | SH | SOLE | 230,000 | 0 | 0 | ||
| PORTOLA PHARMACEUTICALS INC | COM | 737010108 | 11,834 | 230,000 | SH | SOLE | 230,000 | 0 | 0 | ||
| ADAPTIMMUNE THERAPEUTICS PLC | SPONDS ADR | 00653A107 | 2,533 | 210,000 | SH | SOLE | 210,000 | 0 | 0 | ||
| SAGE THERAPEUTICS INC | COM | 78667J108 | 11,660 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| CYNAPSUS THERAPEUTICS INC | COM PAR NO PAR | 23257Y859 | 2,318 | 151,630 | SH | SOLE | 151,630 | 0 | 0 | ||
| ENTELLUS MED INC | COM | 29363K105 | 2,529 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| MALLINCKRODT PUB LTD CO | SHS | G5785G107 | 10,075 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
| CORIUM INTL INC | COM | 21887L107 | 1,015 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| OCERA THERAPEUTICS INC | COM | 67552A108 | 390 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| BLUEBIRD BIO INC | COM | 09609G100 | 7,706 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
| INTEGRA LIFESCIENCES HLDGS C | COM NEW | 457985208 | 8,134 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
| ACORDA THERAPEUTICS INC | COM | 00484M106 | 4,278 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 4,150 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 3,858 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| PROTHENA CORP PLC | SHS | G72800108 | 6,130 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
| DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 5,314 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
| AMGEN INC | COM | 031162100 | 12,175 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| REGENXBIO INC | COM | 75901B107 | 996 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
| DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | 1,329 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | ||
| INCYTE CORP | COM | 45337C102 | 5,423 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| AKARI THERAPEUTICS PLC | SPONSORED ADR | 00972G108 | 683 | 47,116 | SH | SOLE | 47,116 | 0 | 0 | ||
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 4,236 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
| PACIRA PHARMACEUTICALS INC | COM | 695127100 | 2,304 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| BIOGEN INC | COM | 09062X103 | 7,659 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
| PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 9,848 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 7,900 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| SEATTLE GENETICS INC | COM | 812578102 | 10,098 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
| RETROPHIN INC | COM | 761299106 | 3,858 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| FLUIDIGM CORP DEL | COM | 34385P108 | 1,622 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| NEVRO CORP | COM | 64157F103 | 5,738 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
| STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 553 | 72,726 | SH | SOLE | 72,726 | 0 | 0 | ||
| WRIGHT MED GROUP N V | ORD SHS 0.03 PAR | N96617118 | 12,090 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | COM | 03152W109 | 970 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
| CLOVIS ONCOLOGY INC | COM | 189464100 | 1,750 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |